Molecular imaging of cancer with positron emission tomography

被引：1297

作者：

Gambhir, SS ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Crump Inst Mol Imaging, Los Angeles, CA 90095 USA

来源：

NATURE REVIEWS CANCER | 2002年 / 2卷 / 09期

关键词：

D O I：

10.1038/nrc882

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The imaging of specific molecular targets that are associated with cancer should allow earlier diagnosis and better management of oncology patients. Positron emission tomography (PET) is a highly sensitive non-invasive technology that is ideally suited for pre-clinical and clinical imaging of cancer biology, in contrast to anatomical approaches. By using radiolabelled tracers, which are injected in non-pharmacological doses, three-dimensional images can be reconstructed by a computer to show the concentration and location(s) of the tracer of interest. PET should become increasingly important in cancer imaging in the next decade.

引用

页码：683 / 693

页数：11

共 106 条

[1] An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer [J].